IAVI and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products for HIV
NEW YORK, Oct. 22, 2018 /PRNewswire/ — The International AIDS Vaccine Initiative (IAVI) and Serum Institute of India, the world’s largest vaccine manufacturer, today announced a strategic partnership to develop and manufacture affordable and accessible monoclonal antibody products for…
View more at https://www.prnewswire.com:443/news-releases/iavi-and-serum-institute-of-india-to-develop-and-manufacture-globally-affordable-and-accessible-antibody-products-for-hiv-300734924.html
Comments Off on IAVI and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products for HIV